Pharmacopsychiatry
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.3 | Q3 | 46.6% | 0.868 | Q2 | 79.9% |
| 2024 | 2.2 | Q3 | 47.6% | 0.943 | Q1 | 82.6% |
| 2023 | 3.6 | Q1 | 75.9% | 0.834 | Q2 | 81.0% |
| 2022 | 4.3 | Q2 | 72.0% | 0.583 | Q2 | 71.1% |
| 2021 | 2.5 | Q3 | 45.8% | 0.942 | Q1 | 85.3% |
| 2020 | — | — | 1.174 | Q1 | 88.5% | |
| 2019 | — | — | 1.003 | Q1 | 85.7% | |
| 2018 | — | — | 0.667 | Q2 | 73.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0176-3679
ISSN
1439-0795
country
DEcoverage
1984-2026